Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken.
Watch this short video to learn why!

Federal Anti-Kickback Statute and Beneficiary Inducements: Remuneration for Clinical Trial Participants

$19.99

Gain crucial insight into the proposed changes affecting remuneration for individuals participating in clinical trials under the Federal anti-kickback statute and Beneficiary Inducements CMP. This course unpacks the latest HHS request for public input, clarifies legal boundaries for payment practices, and prepares stakeholders to contribute effectively to ongoing regulatory discussions. Learn what types of compensation are being considered, the safeguards under review, and how your feedback can shape future compliance requirements in federally funded health programs.

In this course you will learn the following:
* Understand the purpose and intent of the RFI and the goals of the OIG in seeking public input.
* Recognize the importance of public participation and how to submit comments.
* Identify the key areas of inquiry and potential changes under consideration regarding remuneration for clinical trial participants.
* Appreciate that the rulemaking process is ongoing and subject to change based on stakeholder feedback.

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.

Why This Course is Important
Without this course, you may overlook important regulatory developments, miss opportunities to provide feedback on proposed payment practices, and risk non-compliance with evolving federal requirements in clinical research.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP.

Key regulatory references include:

Course SKU
FR-26-2022-1

About Benchmarks:

Are you ready for this regulation? Use this benchmark to find out.

Each benchmark is build directly for the federal regulation.  They reflect the learning objectives of the related course.

The benchmark is not a “trivia test” – they help you evaluate your readiness to apply the new regulation.

Contact us for more information and/or personalized benchmarks for your specific organization/industry.

Federal Anti-Kickback Statute and Beneficiary Inducements: Remuneration for Clinical Trial Participants

Gain crucial insight into the proposed changes affecting remuneration for individuals participating in clinical trials under the Federal anti-kickback statute and Beneficiary Inducements CMP. This course unpacks the latest HHS request for public input, clarifies legal boundaries for payment practices, and prepares stakeholders to contribute effectively to ongoing regulatory discussions. Learn what types of compensation are being considered, the safeguards under review, and how your feedback can shape future compliance requirements in federally funded health programs.

In this course you will learn the following:
* Understand the purpose and intent of the RFI and the goals of the OIG in seeking public input.
* Recognize the importance of public participation and how to submit comments.
* Identify the key areas of inquiry and potential changes under consideration regarding remuneration for clinical trial participants.
* Appreciate that the rulemaking process is ongoing and subject to change based on stakeholder feedback.

NOTE: Unless otherwise indicated, all Benchmarks are free of charge!

Why This Course is Important
Without this course, you may overlook important regulatory developments, miss opportunities to provide feedback on proposed payment practices, and risk non-compliance with evolving federal requirements in clinical research.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP.

Key regulatory references include:

Course SKU
FR-26-2022-1

Replenish your Studio Course Advisor Unit balance here . Please contact frsales@courseavenue.com if you need to purchase more. Talk to use about an Enterprise License to see if that is right for you!

Federal Anti-Kickback Statute and Beneficiary Inducements: Remuneration for Clinical Trial Participants

$19.99

Why This Course is Important
Without this course, you may overlook important regulatory developments, miss opportunities to provide feedback on proposed payment practices, and risk non-compliance with evolving federal requirements in clinical research.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP.

Key regulatory references include:

Course SKU
FR-26-2022-1

Gain crucial insight into the proposed changes affecting remuneration for individuals participating in clinical trials under the Federal anti-kickback statute and Beneficiary Inducements CMP. This course unpacks the latest HHS request for public input, clarifies legal boundaries for payment practices, and prepares stakeholders to contribute effectively to ongoing regulatory discussions. Learn what types of compensation are being considered, the safeguards under review, and how your feedback can shape future compliance requirements in federally funded health programs.

In this course you will learn the following:
* Understand the purpose and intent of the RFI and the goals of the OIG in seeking public input.
* Recognize the importance of public participation and how to submit comments.
* Identify the key areas of inquiry and potential changes under consideration regarding remuneration for clinical trial participants.
* Appreciate that the rulemaking process is ongoing and subject to change based on stakeholder feedback.

Related products